Controlling multidrug-resistant Gram-negative bacilli in your hospital: a transformational journey

被引:12
|
作者
Munoz-Price, L. S. [1 ,2 ]
机构
[1] Med Coll Wisconsin, Inst Hlth & Soc, Milwaukee, WI 53226 USA
[2] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA
关键词
Acinetobacter baumannii; Carbapenem; Multidrug-resistant Gram-negative organisms; Resistance; ACINETOBACTER-BAUMANNII; CARBAPENEM-RESISTANT; ENVIRONMENTAL CONTAMINATION; PATIENT ROOMS; ENTEROBACTERIACEAE; POWDER;
D O I
10.1016/j.jhin.2015.02.006
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
During the past two decades, the world has experienced a proliferation of multidrug-resistant Gram-negative organisms. This paper is an account of the author's personal experience of implementing a bundle of interventions aimed at controlling carbapenem-resistant Acinetobacter baumannii, and of the cultural transformation that was required for effective control. (C) 2015 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:254 / 258
页数:5
相关论文
共 50 条
  • [11] Combination antibiotic therapy for multidrug-resistant Gram-negative bacteria
    Tangden, Thomas
    UPSALA JOURNAL OF MEDICAL SCIENCES, 2014, 119 (02) : 149 - 153
  • [12] Re-evaluating the approach to drug target discovery in multidrug-resistant Gram-negative bacilli
    Umland, Timothy C.
    Schultz, L. Wayne
    Russo, Thomas A.
    FUTURE MICROBIOLOGY, 2014, 9 (10) : 1113 - 1116
  • [13] Prevalence of Multidrug-Resistant Gram-Negative Bacteria in Saudi Arabia: Meta Review
    Alshammari, Naheda
    Aly, Magda
    Al-Abdullah, Nabeela
    BIOSCIENCE BIOTECHNOLOGY RESEARCH COMMUNICATIONS, 2021, 14 (01): : 12 - 19
  • [14] Risk factors for pneumonia caused by multidrug-resistant Gram-negative bacilli among liver recipients
    Shi, Shao Hua
    Kong, Hai Shen
    Jia, Chang Ku
    Zhang, Wen Jin
    Xu, Jian
    Wang, Wei Lin
    Shen, Yan
    Zhang, Min
    Zheng, Shu Sen
    CLINICAL TRANSPLANTATION, 2010, 24 (06) : 758 - 765
  • [15] Multidrug-resistant Gram-negative infections: the use of colistin
    Michalopoulos, Argyris S.
    Karatza, Dimitra C.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2010, 8 (09) : 1009 - 1017
  • [16] Genomic epidemiology of multidrug-resistant Gram-negative organisms
    Hawken, Shawn E.
    Snitkin, Evan S.
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2019, 1435 (01) : 39 - 56
  • [17] Risk of acquiring multidrug-resistant Gram-negative bacilli from prior room occupants in the intensive care unit
    Nseir, S.
    Blazejewski, C.
    Lubret, R.
    Wallet, F.
    Courcol, R.
    Durocher, A.
    CLINICAL MICROBIOLOGY AND INFECTION, 2011, 17 (08) : 1201 - 1208
  • [18] Treatment of Multidrug-Resistant Gram-Negative Infections in Children
    Hsu, Alice J.
    Tamma, Pranita D.
    CLINICAL INFECTIOUS DISEASES, 2014, 58 (10) : 1439 - 1448
  • [19] The role of fosfomycin for multidrug-resistant gram-negative infections
    Bassetti, Matteo
    Graziano, Elena
    Berruti, Marco
    Giacobbe, Daniele Roberto
    CURRENT OPINION IN INFECTIOUS DISEASES, 2019, 32 (06) : 617 - 625
  • [20] The Dilemma of Multidrug-Resistant Gram-Negative Bacteria
    Engel, Lee S.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2010, 340 (03) : 232 - 237